{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:48:08Z","timestamp":1787312888505,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-12227-5","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T06:09:55Z","timestamp":1737180595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cost-effectiveness and budget impact analysis of peritoneal dialysis and haemodialysis in South Africa"],"prefix":"10.1186","volume":"25","author":[{"given":"Evelyn","family":"Thsehla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheal Kofi","family":"Boachie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"issue":"7","key":"12227_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20(7):473\u201385.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"12227_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022;12(1):7\u201311.","journal-title":"Kidney Int Suppl (2011)"},{"issue":"5","key":"12227_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41581-020-0268-7","volume":"16","author":"EF Carney","year":"2020","unstructured":"Carney EF. The impact of chronic kidney disease on global health. Nat Rev Nephrol. 2020;16(5):251\u2013251.","journal-title":"Nat Rev Nephrol"},{"issue":"10225","key":"12227_CR4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"B Bikbov","year":"2020","unstructured":"Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709\u201333.","journal-title":"Lancet"},{"issue":"1","key":"12227_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12882-023-03109-1","volume":"24","author":"S Hariparshad","year":"2023","unstructured":"Hariparshad S, Bhimma R, Nandlal L, Jembere E, Naicker S, Assounga A. The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally. BMC Nephrol. 2023;24(1):62.","journal-title":"BMC Nephrol"},{"issue":"3","key":"12227_CR6","first-page":"363","volume":"10","author":"AB Adeniyi","year":"2017","unstructured":"Adeniyi AB, Laurence CE, Volmink JA, Davids MR. Prevalence of chronic kidney disease and association with cardiovascular risk factors among teachers in Cape Town,\u00a0South Africa. Clin Kidney J. 2017;10(3):363\u20139.","journal-title":"Clin Kidney J."},{"issue":"4","key":"12227_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.7196\/SAMJ.9535","volume":"105","author":"MR Moosa","year":"2015","unstructured":"Moosa MR, Van der Walt I, Naicker S, Meyers AM. Important causes of chronic kidney disease in South Africa. S Afr Med J. 2015;105(4):320.","journal-title":"S Afr Med J"},{"issue":"3","key":"12227_CR8","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3390\/jcm13030678","volume":"13","author":"F Mallamaci","year":"2024","unstructured":"Mallamaci F, Tripepi G. Risk factors of chronic kidney disease progression: between old and new concepts. J Clin Med. 2024;13(3):678.","journal-title":"J Clin Med"},{"key":"12227_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2147\/HIV.S396949","volume":"15","author":"N Wearne","year":"2023","unstructured":"Wearne N, Davidson B, Blockman M, Jones J, Ross IL, Dave JA. Management of type 2 diabetes mellitus and kidney failure in people with HIV-infection in Africa: current status and a call to action. HIV\/AIDS Res Palliat Care. 2023;15:519\u201335.","journal-title":"HIV\/AIDS Res Palliat Care"},{"issue":"11","key":"12227_CR10","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, B\u00f6hm M, Marx N. Cardiovascular disease in chronic kidney disease. Circulation. 2021;143(11):1157\u201372.","journal-title":"Circulation"},{"issue":"4","key":"12227_CR11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","volume":"105","author":"A Levin","year":"2024","unstructured":"Levin A, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al. Executive summary of the KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease: known knowns and known unknowns. Kidney Int. 2024;105(4):684\u2013701.","journal-title":"Kidney Int"},{"issue":"4","key":"12227_CR12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.pop.2020.08.001","volume":"47","author":"C Charles","year":"2020","unstructured":"Charles C, Ferris AH. Chronic kidney disease. Prim Care. 2020;47(4):585\u201395.","journal-title":"Prim Care"},{"issue":"10","key":"12227_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41581-020-0315-4","volume":"16","author":"J Himmelfarb","year":"2020","unstructured":"Himmelfarb J, Vanholder R, Mehrotra R, Tonelli M. The current and future landscape of dialysis. Nat Rev Nephrol. 2020;16(10):573\u201385.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"12227_CR14","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1016\/S2214-109X(23)00570-3","volume":"12","author":"AK Bello","year":"2024","unstructured":"Bello AK, Okpechi IG, Levin A, Ye F, Damster S, Arruebo S, et al. An update on the global disparities in kidney disease burden and care across world countries and regions. Lancet Glob Health. 2024;12(3):e382\u201395.","journal-title":"Lancet Glob Health"},{"issue":"2","key":"12227_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000514550","volume":"52","author":"JS Thurlow","year":"2021","unstructured":"Thurlow JS, Joshi M, Yan G, Norris KC, Agodoa LY, Yuan CM, et al. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol. 2021;52(2):98\u2013107.","journal-title":"Am J Nephrol"},{"issue":"1","key":"12227_CR16","first-page":"155","volume":"25","author":"MR Davids","year":"2022","unstructured":"Davids MR, Jardine T, Marais N, Sebastian S, Jacobs J. South African renal registry annual report 2020. Afr J Nephrol. 2022;25(1):155\u201366.","journal-title":"Afr J Nephrol."},{"key":"12227_CR17","unstructured":"Council for Medical Schemes. Industry Report 2021. Council for Medical Schemes. Pretoria; 2022."},{"issue":"4","key":"12227_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s41669-019-0124-5","volume":"3","author":"L Makhele","year":"2019","unstructured":"Makhele L, Matlala M, Sibanda M, Martin AP, Godman B. A cost analysis of haemodialysis and peritoneal dialysis for the management of end-stage renal failure at an academic hospital in Pretoria, South Africa. Pharmacoecon Open. 2019;3(4):631\u201341.","journal-title":"Pharmacoecon Open"},{"issue":"1","key":"12227_CR19","doi-asserted-by":"publisher","first-page":"30266","DOI":"10.1038\/srep30266","volume":"6","author":"YT Chang","year":"2016","unstructured":"Chang YT, Hwang JS, Hung SY, Tsai MS, Wu JL, Sung JM, et al. Cost-effectiveness of hemodialysis and peritoneal dialysis: a national cohort study with 14 years follow-up and matched for comorbidities and propensity score. Sci Rep. 2016;6(1):30266.","journal-title":"Sci Rep"},{"issue":"10","key":"12227_CR20","doi-asserted-by":"publisher","first-page":"e0218422","DOI":"10.1371\/journal.pone.0218422","volume":"14","author":"NK Surendra","year":"2019","unstructured":"Surendra NK, Abdul Manaf MR, Hooi LS, Bavanandan S, Mohamad Nor FS, Firdaus Khan SS, et al. Cost utility analysis of end stage renal disease treatment in ministry of health dialysis centres, Malaysia: hemodialysis versus continuous ambulatory peritoneal dialysis. PLoS ONE. 2019;14(10):e0218422.","journal-title":"PLoS ONE"},{"issue":"1","key":"12227_CR21","first-page":"83","volume":"26","author":"MR Davids","year":"2023","unstructured":"Davids MR, Marais N, Sebastian S, Jardine T, Jacobs JC. South African renal registry annual report 2021. Afr J Nephrol. 2023;26(1):83\u201394.","journal-title":"Afr J Nephrol"},{"issue":"1","key":"12227_CR22","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1186\/s12913-023-10109-2","volume":"23","author":"K Moalosi","year":"2023","unstructured":"Moalosi K, Sibanda M, Kurdi A, Godman B, Matlala M. Estimated indirect costs of haemodialysis versus peritoneal dialysis from a patients\u2019 perspective at an Academic Hospital in Pretoria, South Africa. BMC Health Serv Res. 2023;23(1):1119.","journal-title":"BMC Health Serv Res"},{"key":"12227_CR23","unstructured":"Crombie K, Wearne N. The 5 year outcomes of patients receiving haemodialysis versus peritoneal dialysis at Groote Schuur Hospital, Cape Town, South Africa. [Cape Town]: University of Cape Town; 2017."},{"issue":"3","key":"12227_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3747\/pdi.2017.00182","volume":"38","author":"B Davidson","year":"2018","unstructured":"Davidson B, Crombie K, Manning K, Rayner B, Wearne N. Outcomes and challenges of a PD-first program, a South-African perspective. Perit Dial Int. 2018;38(3):179\u201386.","journal-title":"Perit Dial Int"},{"key":"12227_CR25","doi-asserted-by":"crossref","unstructured":"Cooper JT, Lloyd A, Sanchez JJG, S\u00f6rstadius E, Briggs A, McFarlane P. Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review. Health Qual Life Outcomes. 2020;18(1):310.","DOI":"10.1186\/s12955-020-01559-x"},{"key":"12227_CR26","unstructured":"National Department of Health. Guidelines for Pharmacoeconomic Submissions. National Department of Health. Pretoria; 2012."},{"key":"12227_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-15744-3","volume-title":"Cost Effectiveness Modelling for Health Technology Assessment","author":"R Edlin","year":"2015","unstructured":"Edlin R, McCabe C, Hulme C, Hall P, Wright J. Cost effectiveness modelling for health technology assessment. Cham: Springer International Publishing; 2015."},{"issue":"3","key":"12227_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jval.2019.01.004","volume":"22","author":"J Brazier","year":"2019","unstructured":"Brazier J, Ara R, Azzabi I, Busschbach J, Chevrou-S\u00e9verac H, Crawford B, et al. Identification, review, and use of health state utilities in cost-effectiveness models: an ISPOR good practices for outcomes research task force report. Value Health. 2019;22(3):267\u201375.","journal-title":"Value Health"},{"issue":"5","key":"12227_CR29","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/heapol\/czz152","volume":"35","author":"IP Edoka","year":"2020","unstructured":"Edoka IP, Stacey NK. Estimating a cost-effectiveness threshold for health care decision-making in South Africa. Health Policy Plan. 2020;35(5):546\u201355.","journal-title":"Health Policy Plan"},{"issue":"7","key":"12227_CR30","doi-asserted-by":"publisher","first-page":"S350","DOI":"10.1016\/j.jval.2022.04.334","volume":"25","author":"R Aroza","year":"2022","unstructured":"Aroza R, Ndai A, Alkhuzam K, Shao H, Jiao T. EE80 cost-effectiveness analysis of hemodialysis vs. peritoneal dialysis among patients with end-stage renal disease. Value Health. 2022;25(7):S350.","journal-title":"Value Health."},{"issue":"1","key":"12227_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1524-4733.2006.00145.x","volume":"10","author":"Y Teerawattananon","year":"2007","unstructured":"Teerawattananon Y, Mugford M, Tangcharoensathien V. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand. Value Health. 2007;10(1):61\u201372.","journal-title":"Value Health."},{"issue":"1","key":"12227_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.xkme.2020.12.003","volume":"3","author":"N Klomjit","year":"2021","unstructured":"Klomjit N, Kattah AG, Cheungpasitporn W. The cost-effectiveness of peritoneal dialysis is superior to hemodialysis: updated evidence from a more precise model. Kidney Med. 2021;3(1):15\u20137.","journal-title":"Kidney Med"},{"issue":"1","key":"12227_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12882-016-0425-1","volume":"18","author":"EK Tannor","year":"2017","unstructured":"Tannor EK, Archer E, Kapembwa K, van Schalkwyk SC, Davids MR. Quality of life in patients on chronic dialysis in South Africa: a comparative mixed methods study. BMC Nephrol. 2017;18(1):4.","journal-title":"BMC Nephrol"},{"issue":"1","key":"12227_CR34","first-page":"176","volume":"23","author":"B Davidson","year":"2020","unstructured":"Davidson B, Welgemoed W, Jones E, Barday Z. Health-related quality of life in a PD-First programme in South Africa. Afr J Nephrol. 2020;23(1):176\u201384.","journal-title":"Afr J Nephrol"},{"issue":"3","key":"12227_CR35","doi-asserted-by":"publisher","first-page":"519","DOI":"10.4103\/1319-2442.111036","volume":"24","author":"I Okpechi","year":"2013","unstructured":"Okpechi I, Nthite T, Swanepoel C. Health-related quality of life in patients on hemodialysis and peritoneal dialysis. Saudi J Kidney Dis Transpl. 2013;24(3):519.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"12227_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.vhri.2015.06.003","volume":"9","author":"S Bavanandan","year":"2016","unstructured":"Bavanandan S, Ahmad G, Teo AH, Chen L, Liu FX. Budget impact analysis of peritoneal dialysis versus conventional in-center hemodialysis in Malaysia. Value Health Reg Issues. 2016;9:8\u201314.","journal-title":"Value Health Reg Issues"},{"key":"12227_CR37","doi-asserted-by":"publisher","first-page":"e001317","DOI":"10.1136\/bmjgh-2018-001317","volume":"4","author":"A Saxena","year":"2019","unstructured":"Saxena A, Stacey N, Puech PDR, Mudara C, Hofman K, Verguet S. The distributional impact of taxing sugar-sweetened beverages: findings from an extended cost-effectiveness analysis in South Africa. BMJ Glob Health. 2019;4:e001317.","journal-title":"BMJ Glob Health."},{"key":"12227_CR38","doi-asserted-by":"publisher","first-page":"101469","DOI":"10.1016\/j.pmedr.2021.101469","volume":"23","author":"KE Charlton","year":"2021","unstructured":"Charlton KE, Corso B, Ware L, Schutte AE, Wepener L, Minicuci N, et al. Effect of South Africa\u2019s interim mandatory salt reduction programme on urinary sodium excretion and blood pressure. Prev Med Rep. 2021;23:101469.","journal-title":"Prev Med Rep"},{"issue":"9","key":"12227_CR39","doi-asserted-by":"publisher","first-page":"743","DOI":"10.7196\/SAMJ.5832","volume":"102","author":"MY Bertram","year":"2012","unstructured":"Bertram MY, Steyn K, Wentzel-Viljoen E, Tollman S, Hofman KJ. Reducing the sodium content of high-salt foods: effect on cardiovascular disease in South Africa. S Afr Med J. 2012;102(9):743.","journal-title":"S Afr Med J"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-12227-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-12227-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-12227-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T06:10:01Z","timestamp":1737180601000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-12227-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12227"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-12227-5","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received an ethics waiver from the University of the Witwatersrand\u2019s Research Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}